207 related articles for article (PubMed ID: 23712051)
1. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.
Poynard T; Moussalli J; Munteanu M; Thabut D; Lebray P; Rudler M; Ngo Y; Thibault V; Mkada H; Charlotte F; Bismut FI; Deckmyn O; Benhamou Y; Valantin MA; Ratziu V; Katlama C;
J Hepatol; 2013 Oct; 59(4):675-83. PubMed ID: 23712051
[TBL] [Abstract][Full Text] [Related]
2. Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection.
Casado JL; Quereda C; Moreno A; Pérez-Elías MJ; Martí-Belda P; Moreno S
J Viral Hepat; 2013 Dec; 20(12):829-37. PubMed ID: 24304452
[TBL] [Abstract][Full Text] [Related]
3. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
Poynard T; Vergniol J; Ngo Y; Foucher J; Munteanu M; Merrouche W; Colombo M; Thibault V; Schiff E; Brass CA; Albrecht JK; Rudler M; Deckmyn O; Lebray P; Thabut D; Ratziu V; de Ledinghen V; ; ;
J Hepatol; 2014 Apr; 60(4):706-14. PubMed ID: 24291240
[TBL] [Abstract][Full Text] [Related]
4. Course of liver fibrosis in HIV-hepatitis C virus-coinfected patients depending on the response to hepatitis C therapy.
Cartón JA; Collazos J; de la Fuente B; Asensi V
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):215-22. PubMed ID: 22734850
[TBL] [Abstract][Full Text] [Related]
5. Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis.
Ingiliz P; Valantin MA; Preziosi P; Finzi L; Pais R; Fedchuk L; Dominguez S; Katlama C; Poynard T; Benhamou Y
J Hepatol; 2012 Jan; 56(1):49-54. PubMed ID: 21781946
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.
D'Ambrosio R; Aghemo A; Fraquelli M; Rumi MG; Donato MF; Paradis V; Bedossa P; Colombo M
J Hepatol; 2013 Aug; 59(2):251-6. PubMed ID: 23528378
[TBL] [Abstract][Full Text] [Related]
7. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients.
ANRS CO13 HEPAVIH Cohort
AIDS; 2015 Sep; 29(14):1821-30. PubMed ID: 26372388
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
[TBL] [Abstract][Full Text] [Related]
9. Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C.
Crisan D; Radu C; Grigorescu MD; Lupsor M; Feier D; Grigorescu M
J Gastrointestin Liver Dis; 2012 Dec; 21(4):375-82. PubMed ID: 23256120
[TBL] [Abstract][Full Text] [Related]
10. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.
D'Ambrosio R; Aghemo A; Rumi MG; Ronchi G; Donato MF; Paradis V; Colombo M; Bedossa P
Hepatology; 2012 Aug; 56(2):532-43. PubMed ID: 22271347
[TBL] [Abstract][Full Text] [Related]
11. Characterization of fibrosis changes in chronic hepatitis C patients after virological cure: A systematic review with meta-analysis.
Liu Z; Wei X; Chen T; Huang C; Liu H; Wang Y
J Gastroenterol Hepatol; 2017 Mar; 32(3):548-557. PubMed ID: 27503423
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
[TBL] [Abstract][Full Text] [Related]
13. Acoustic radiation force impulse imaging for evaluation of antiviral treatment response in chronic hepatitis C.
Forestier N; Gaus A; Herrmann E; Sarrazin C; Bojunga J; Poynard T; Albert J; Gerber L; Schneider MD; Dultz G; Zeuzem S; Friedrich-Rust M
J Gastrointestin Liver Dis; 2012 Dec; 21(4):367-73. PubMed ID: 23256119
[TBL] [Abstract][Full Text] [Related]
14. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
[TBL] [Abstract][Full Text] [Related]
15. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.
Noureddin M; Wong MM; Todo T; Lu SC; Sanyal AJ; Mena EA
World J Gastroenterol; 2018 Mar; 24(11):1269-1277. PubMed ID: 29568207
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.
Loko MA; Bani-Sadr F; Valantin MA; Lascoux-Combe C; Fontaine H; Bonnard P; Gervais A; Bouchaud O; Garipuy D; Quertainmont Y; Vittecoq D; Tehrani MS; Winnock M; Dabis F; Salmon D;
Antivir Ther; 2012; 17(7):1335-43. PubMed ID: 23052829
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.
Casado JL; Esteban MA; Bañón S; Moreno A; Perez-Elías MJ; Mateos ML; Moreno S; Quereda C
Dig Dis Sci; 2015 Nov; 60(11):3473-81. PubMed ID: 26112991
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long-term follow-up.
Maruoka D; Imazeki F; Arai M; Kanda T; Fujiwara K; Yokosuka O
J Viral Hepat; 2012 Feb; 19(2):e97-104. PubMed ID: 22239532
[TBL] [Abstract][Full Text] [Related]
19. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
Poynard T; Vergniol J; Ngo Y; Foucher J; Thibault V; Munteanu M; Merrouche W; Lebray P; Rudler M; Deckmyn O; Perazzo H; Thabut D; Ratziu V; de Ledinghen V;
J Hepatol; 2014 Nov; 61(5):994-1003. PubMed ID: 25016224
[TBL] [Abstract][Full Text] [Related]
20. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
Zarski JP; Sturm N; Guechot J; Paris A; Zafrani ES; Asselah T; Boisson RC; Bosson JL; Guyader D; Renversez JC; Bronowicki JP; Gelineau MC; Tran A; Trocme C; De Ledinghen V; Lasnier E; Poujol-Robert A; Ziegler F; Bourliere M; Voitot H; Larrey D; Rosenthal-Allieri MA; Fouchard Hubert I; Bailly F; Vaubourdolle M;
J Hepatol; 2012 Jan; 56(1):55-62. PubMed ID: 21781944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]